Richard Pzena
Pzena Investment Management
Richard Pzena Quest Diagnostics Incorporated stake
total: 584
Pzena Investment Management DGX trades
- Total transactions:
- 9
- New positions:
- 2
- Sold out:
- 2
- Added:
- 2
- Reduced:
- 3
- Held since:
- 2022 Q1
- Held for:
- 3 quarters
- Latest activity:
- 2022 Q4
According to 2026 Q2 report, Richard Pzena doesn't hold any Quest Diagnostics Incorporated (DGX) shares. Pzena Investment Management has held DGX since at least 2013 Q2 with 665,375 shares in our earliest available record. Richard Pzena later completely sold out the position and invested in Quest Diagnostics Incorporated again in 2022 Q1. Since at least 2013 Q2, Pzena Investment Management has made 8 more transactions.
When did Richard Pzena sell Quest Diagnostics Incorporated (DGX)?
Richard Pzena sold off the entire Quest Diagnostics Incorporated (DGX) position in 2022 Q4.
Estimated cost basis*
- Weighted AVG buy price:
- $136.83
- Weighted AVG sell price:
- $122.58
Richard Pzena's historical trades in Quest Diagnostics Incorporated
9 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q4
|
0.00%
|
0
|
$122.58
|
|
-100% (-1,966)
|
-0%
|
|
2022 Q1
|
0.00%
|
1,966
|
$136.83
|
$269,000
|
new
|
+0%
|
|
2014 Q4
|
0.00%
|
$60.68
|
-100% (-429,700)
|
|||
|
2014 Q3
|
0.14%
|
$60.68
|
-0.32% (-1,400)
|
|||
|
2014 Q2
|
0.14%
|
$58.69
|
-55.66% (-541,100)
|
|||
|
2014 Q1
|
0.32%
|
$57.92
|
-19.99% (-242,850)
|
|||
|
2013 Q4
|
0.38%
|
$53.54
|
+81.17% (+544,400)
|
|||
|
2013 Q3
|
0.27%
|
$61.79
|
+0.79% (+5,275)
|
|||
|
2013 Q2
|
0.27%
|
$60.63
|
new or own*
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.